European approval, European partner, and Belviq product launch
Wildcard.... Eisai announces first production run is sold out before the first shipment.
Quite succinct - but spot on.
The age old question: WHO sells at 9.00s? I would understand if they had run it up, or run it down, catching MoMo's who bought too high in the first case, or people who had a tidy profit in the 2nd case.
As it is, no one has made money at 9.00s. Shorts are desperate for shares, and have held down quite long enough.
I expect the next playground level to be around 9.50... and if CHMP comes in, then $10 or more.
Chrisanja, You are a good poster, but I have to disagree that nobody has made money on Arena yet. There are millions of shares in the hands of retail that were purchased at sub $3 levels, who have a huge paper profit. We had a 350% run in 2012, so there is a ton of profit out there, it's a matter of when it is realized, and how much.
I'm looking for $20 or better myself.
Sentiment: Strong Buy
DEA scheduling..... then longer term is the other products where you go through the FDA circle all over again. Baby bio's are hard to tummy but! can be fun and rewarding when you hit the big one. This will be a big one